Metabolic syndrome is an increasing issue in the US. What factors contribute to development Metabolic syndrome is an increasing issue in the US. What factors contribute to development of the syndrome, who is more at risk for this syndrome, and how does this syndrome intersect for higher rates of obesity and the development of increase risks of heart disease, stroke and type 2 diabetes? What pharmacology intervention and interprofessional input may help control aspects of metabolic syndrome? Locate at least one scholarly source that addresses this topic in support of your perspective in a 250-word initial post. Two peer response posts should include at a minimum 100 words, to extend the discussion.

 

Expert Answer and Explanation

Metabolic Syndrome

Metabolic syndrome can be said to be a collection of correlated conditions that can occur together that increases the risk of a person obtaining stroke, diabetes, and heart disease, some of the main components of metabolic syndrome include high blood pressure and obesity among several others (Xu et al., 2019). Some factors could contribute to the development of the syndrome. Some of these components include physical inactivity, lifestyle, genetic factors, insulin resistance, and obesity.

These factors affect the digestion and fat storage processes in a person which has the capacity to increase the pressure of the blood and also lead to heart disease. Different people are more at risk of having metabolic syndrome than others due to a number of underlying conditions (Xu et al., 2019). For instance, increasing age, people with a genetic history of the condition, and those who have no or limited physical activities have a higher chance of encountering metabolic syndrome.

Metabolic syndrome intersects with higher rates of obesity since the primary cause for high blood pressure and other underlying condition of the heart can be derived from the fatty deposits in the arteries. Obese individuals can then have an increased risk of heart disease type 2 diabetes and stroke due to the high pressure of blood and the energy and rate at which the heart beats to compensate for the resistance (Myers et al., 2019).

Some of the pharmacological interventions for metabolic syndrome that can be implemented by the interprofessional teams include the use of statins to help improve the lipid profiles of the patient or the use of metformin to lower the prevalence of low HDL. The patient can also make use of lifestyle changes such as increasing physical activities, lose weight and change dietary intake.

References

Myers, J., Kokkinos, P., & Nyelin, E. (2019). Physical activity, cardiorespiratory fitness, and the metabolic syndrome. Nutrients, 11(7), 1652.

Xu, H., Li, X., Adams, H., Kubena, K., & Guo, S. (2019). Etiology of metabolic syndrome and dietary intervention. International journal of molecular sciences, 20(1), 128.

Order this paper